Lead pick
Loading…
- Target
- —
- To target
- —
- Posted
- —
Stats
- Mkt Cap
- —
- P/E (TTM)
- —
- 52W Range
- —
- Day Range
- —
- Volume
- —
- Avg Volume
- —
Equity research · Semis · AI · Commodities
Independent equity research across the names I track most closely — semis and AI infrastructure (Micron, NVDA, AMD), energy (XOM, CVX), and the commodities + macro layer that drives them. Through-cycle valuation is the lens, built on an audited DCF pipeline I wrote myself. My team out of Cal State Fullerton won the 2023 CFA Institute Research Challenge for the Americas. The writing, calculators, and demo workbooks are free; the full IB-grade workbooks and Python pipelines are paid. Everything is published with the same audit standards.
Just published · October 3, 2026 · Coverage initiation
Initiating Vistra at HOLD with a $140 price target. The business is hedged through 2027, the nuclear contracts are real, and we agree with consensus on the next two years of earnings. The disagreement is the discount rate: with the 10-year at 5.26%, the Street’s $218 average target needs about a 6.5% WACC, and even on consensus EBITDA our DCF reaches $161. Four valuation lenses, the 2028 hedge gap, the levels we would act on — plus the full 18-page report and model, free.
Read the initiation →
Just shipped · June 2026 · Valuation
Five browser calculators that run the whole arc — value, target, size. Reverse DCF (the FCF growth the market's already pricing in), EPV (the no-growth floor), Through-Cycle PT (normalized EPS × recovery multiple, probability-weighted), Accretion / Dilution (first-year deal EPS), and Position Sizing (Kelly, half by default). All free, browser-only, and shareable by URL.
Open the calculator →
Live prices and news via TradingView. Targets and theses are mine — not investment advice. Disclaimer.
Lead pick
Stats
Loading markets…
Published · May 2026 · Memory / semis
The first full pitch is live: HBM contribution to the next cycle peak, mid-cycle EBIT margin normalisation, what today's price implicitly requires via reverse-DCF, and the bear-case kill shot.
Read the pitch →
Plug in revenue, margin, WACC, terminal growth. Watch the implied share price move live, see a sensitivity grid.
Open →
19-tab IB-grade workbook + Python pipeline. Rebuilds for any ticker in 30 seconds. Cyclical adjustments built in. Demo free.
Open →
Solve the LBO backward. Target IRR → max entry multiple → implied take-private price. Worked MU and WDC examples ship as one-click presets.
Open →
17-tab workbook with cycle diagnostic, returns attribution, reverse-LBO. Two MU worked examples (through-cycle + AI-cycle).
Open →
Reverse-LBO, returns waterfall, distribution waterfall, cap table & waterfall, QofE quick-check — all browser-only. Plus the 8-tab Reverse-LBO Template (free, pipeline on request) and a 30-deal hand-curated take-private precedents database.
The Micron name read through a sponsor's lens. Through-cycle vs AI-cycle scorecards disagree by ~$35 of implied take-private price. The spread between them is the structural call.
Reverse-LBO at 22% sponsor IRR on Western Digital after the SanDisk spin. Math works at modest premium; the friction list is what would actually kill the deal.
17-tab workbook shipped as two worked Micron scorecards (through-cycle + AI-cycle) so methodology disagreement is explicit. Returns attribution, reverse-LBO, covenant tracking, accretion/dilution.
20-tab Excel workbook with a worked Micron example: two-stage FCFF DCF, peer-blended multiples, three scenarios, reverse-DCF decomposition.
19-tab workbook with a Python pipeline that rebuilds for any ticker in 30 seconds. Football Field, Mini-DCF, WACC, Cyclical Adjustments. Demo free; Standard $79; Pro $249.
Through-cycle thesis on Micron Technology against a cyclical comp. Workbook finalised; write-up in progress.
XOM, CVX, COP, SHEL, BP ranked on through-cycle capital allocation discipline against the commodity strip.
Updated every few weeks on the /now page. The full reading list — foundations, sectoral, capital allocation & sponsor capital — lives there.
New essays and research notes, sent occasionally. No spam, unsubscribe any time.
Or subscribe directly on Substack: bpleon.substack.com